Biomet recalled 98 units of its ZipTight Acute AC Joint Implant on September 23, 2025. The recall follows reports of a potential missing slotted button assembly in one lot. Patients and healthcare providers must stop using the device immediately.
There is a potential for a missing slotted button assembly in one lot of ZipTight, Acute AC Joint Implant, Single Ziploop
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Biomet, Inc. or your healthcare provider for instructions
The recall affects the Biomet ZipTight Acute AC Joint Implant, Model/Catalog Number 904834. The affected lot number is 0002587666. These implants were distributed to multiple domestic consignees.
A missing slotted button assembly could compromise the device's effectiveness. This defect poses a high risk to patients receiving this implant.
No specific incidents have been reported. However, due to the potential malfunction, the risk of surgical complications is significant.
Patients and healthcare providers should stop using the device immediately. Contact Biomet, Inc. or your healthcare provider for further instructions.
For more information, visit the FDA recall page at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=Z-0212-2026.
Get notified about recalls in categories you care about.
Bristol-Myers Squibb recalled 12,778 vials of Opdualag injection on October 21, 2025. The recall stems from a lack of assurance of sterility. The affected products were distributed nationwide in the United States.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.